Cambridge Investment Research Advisors, Inc.

Position in CORT — Corcept Therapeutics Inc

CIK 1419186 FAIRFIELD, IA

Position in CORT

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$3,056,901

+$1,333,488 QoQ

Shares Held

35,157

-17.8% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#126

of 421 holders

Holding Since

Mar 2023

13 quarters on record

Healthcare · as of Jun 30, 2026

Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. CORT ranks #4 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	21,946	$10,901,236
2	EXEL	Exelixis, Inc.	82,212	$4,473,154
3	NKTR	Nektar Therapeutics	56,186	$3,922,344
4	CORT	Corcept Therapeutics Inc This page	35,157	$3,056,901
5	RVMD	Revolution Medicines, Inc.	15,839	$2,966,327
6	REGN	Regeneron Pharmaceuticals, Inc.	4,591	$2,862,672
7	CRSP	CRISPR Therapeutics AG	46,210	$2,520,293
8	BBIO	BridgeBio Pharma, Inc.	30,727	$2,288,546

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,056,901	35,157	-17.8%	Shares	Sole	2026-07-30
2026-03-31	$1,723,413	42,754	+26.7%	Shares	Sole	2026-04-30
2025-12-31	$1,174,326	33,745	+125.8%	Shares	Sole	2026-02-05
2025-09-30	$1,241,912	14,943	+45.5%	Shares	Sole	2025-11-12
2025-06-30	$753,964	10,272	-14.4%	Shares	Sole	2025-07-31
2025-03-31	$1,371,211	12,005	-39.3%	Shares	Sole	2025-04-22
2024-12-31	$996,008	19,766	-26.4%	Shares	Sole	2025-02-14
2024-09-30	$1,242,849	26,855	-90.6%	Shares	Sole	2024-10-28
2024-06-30	$9,300,262	286,250	-11.7%	Shares	Sole	2024-07-26
2024-03-31	$8,168,386	324,271	+2922.7%	Shares	Sole	2024-04-24
2023-12-31	$348,445	10,728	-93.8%	Shares	Sole	2024-02-09
2023-09-30	$4,726,567	173,452	-52.6%	Shares	Sole	2023-10-24
2023-03-31	$7,932,325	366,220	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.